Streetbeat News

Products Services

MRVL

Marvell's stock has increased by 18% since July, driven by growth in the AI infrastructure market. The company targets a 20% share of the $40 billion custom AI chip market, with significant growth expected in 2025. Recovery in non-AI segments is also anticipated to boost revenue.

Portfolio Pulse from

November 07, 2024 | 7:30 am

SHOP

Brizy has launched a new no-code landing page builder app for Shopify, allowing store owners to create visually appealing and high-converting pages easily.

Portfolio Pulse from

November 07, 2024 | 7:15 am

BNO

Vitol CEO Russell Hardy predicts global oil prices will remain in the $70 to $80 per barrel range in 2025, similar to 2024, with geopolitical risks contributing to supply uncertainty.

Portfolio Pulse from

November 07, 2024 | 6:45 am

ZLDPF

Zealand Pharma plans to start a phase 2b trial for its obesity drug candidate, petrelintide, in Q4 2024.

Portfolio Pulse from

November 07, 2024 | 6:45 am

FLNG

Flex LNG Ltd has secured a time charter extension for its LNG carriers, Flex Courageous and Flex Resolute, with a Supermajor. The new firm period is from 2029 to 2032, with an option to extend until 2039.

Portfolio Pulse from

November 07, 2024 | 6:45 am

BNO

Geopolitical tensions and risks to Gulf supply are causing an increase in oil and natural gas prices. The article provides a forecast for market movements and key levels to watch.

Portfolio Pulse from

November 07, 2024 | 6:30 am

BIZD

PBDC

Putnam BDC Income ETF (PBDC) outperforms peers by focusing on high-quality BDCs, offering a 9% yield and a balanced approach to dividend sustainability and growth. Its dividend is well-supported by net investment income, making it resilient in various market conditions.

Portfolio Pulse from

November 07, 2024 | 6:30 am

VALN

Valneva SE reported strong financial results for the first nine months of 2024, with total revenues of €116.6 million and a net profit of €24.7 million. The company has launched the world's first chikungunya vaccine in Canada and Europe and is expanding its strategic pipeline with new vaccine candidates. Valneva's financial guidance for 2024 includes expected product sales between €160 million and €170 million.

Portfolio Pulse from

November 07, 2024 | 6:15 am

PLTR

Palantir, known as the 'Messi of AI growth,' continues to exceed expectations with strong performance and raised guidance. Despite its impressive business model and high customer retention, the stock is rated as Hold due to high valuation. However, short-term momentum is possible.

Portfolio Pulse from

November 07, 2024 | 5:00 am

PACB

PacBio has introduced the Vega System, a new benchtop sequencing platform priced at $169,000, aimed at making highly accurate long-read sequencing accessible to more laboratories.

Portfolio Pulse from

November 07, 2024 | 3:45 am